**Question:** Which of the following is NOT used in post-exposure prophylaxis for HIV?

A. Zidovudine (AZT)
B. Tenofovir
C. Lamivudine
D. Efavirenz

**Core Concept:** Post-exposure prophylaxis (PEP) for HIV is a regimen of antiretroviral medications taken within 72 hours after a potential HIV exposure to reduce the risk of HIV infection. These medications aim to suppress HIV replication and reduce viral load.

**Why the Correct Answer is Right:** Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination antiretroviral therapy (ART) for treating HIV infection. In the context of PEP, its use would be inappropriate because its primary role is in treating established HIV infection, not preventing it.

**Why Each Wrong Option is Incorrect:**

A. Zidovudine (AZT) is a nucleoside reverse transcriptase inhibitor (NRTI) used in both PEP and ART regimens. It is an effective drug for HIV prevention when initiated within the recommended time frame.

B. Tenofovir is also a NRTI and is used in ART regimens. Although not as commonly used as AZT, it is effective in HIV prevention when initiated promptly.

C. Lamivudine is a NRTI used in ART regimens. Like AZT and tenofovir, it is effective in preventing HIV infection when initiated within the recommended time frame.

**Clinical Pearl:** This question highlights the importance of considering the specific role of each antiretroviral medication for proper selection and timing in post-exposure prophylaxis. Timely initiation of appropriate antiretroviral regimens is crucial for the success of PEP in preventing HIV infection.